New York Life Investment Management’s Stepan Co SCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,067
Closed -$366K 1240
2024
Q1
$366K Buy
4,067
+690
+20% +$61.8K ﹤0.01% 1077
2023
Q4
$319K Sell
3,377
-78
-2% -$6.23K ﹤0.01% 1181
2023
Q3
$259K Sell
3,455
-545
-14% -$47.6K ﹤0.01% 1229
2023
Q2
$382K Sell
4,000
-651
-14% -$61.8K ﹤0.01% 1072
2023
Q1
$479K Sell
4,651
-1,090
-19% -$114K 0.01% 915
2022
Q4
$611K Buy
5,741
+616
+12% +$64.6K 0.01% 757
2022
Q3
$480K Buy
5,125
+405
+9% +$42.1K 0.01% 775
2022
Q2
$478K Buy
+4,720
New +$488K 0.01% 752

Other funds holding SCL

New York Life Investment Management's SCL Position: Q2 2024 in Review

New York Life Investment Management sold out of Stepan Co (SCL) in Q2 2024, closing a stake of 4,067 shares — an estimated $366K sold.

New York Life Investment Management first reported a position in SCL in Q2 2022 and held it in 8 quarters. The position peaked at $611K in Q4 2022. 215 funds tracked by Wall St. Rank hold SCL as of Q2 2024.

  • New York Life Investment Management reported no remaining Stepan Co position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 4,067 Stepan Co shares in Q2 2024, an estimated $366K.
  • New York Life Investment Management first reported a position in Stepan Co in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Stepan Co position peaked at $611K in Q4 2022.
  • 215 funds tracked by Wall St. Rank held Stepan Co as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.